@petalopharma@amitisinvesting@OpenAINewsroom That’s a good point and something I’m not aware of. I would think for this to work out long term it would require some “proof of shares”.
Interested to see how this develops as we learn more about it. New products often come with more scrutiny.
@amitisinvesting@OpenAINewsroom This is the on-chain version of American Depository Receipts “ADRs” which are used to have access to foreign companies.